Clinical Trial

Intracerebroventricular Tralesinidase Alfa in Participants With MPS IIIB (Sanfilippo Syndrome Type B)

Name: Intracerebroventricular Tralesinidase Alfa in Participants With MPS IIIB (Sanfilippo Syndrome Type B) — clinical trial record (NCT07579910)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: TrAnsform

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

The primary objectives of this study are to evaluate the effects of Tralesinidase Alfa (TA) on cognition

Trial Details

NCT Number	NCT07579910
Lead Sponsor	Spruce Biosciences
Conditions	MPS IIIB
Enrollment	14 participants
Start Date	2026-12
Primary Completion	2033-08 (estimated)
Study Completion	2033-08 (estimated)
Updated on ClinicalTrials.gov	2026-07-30